Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Shanghai Journal of Preventive Medicine ; 34(11):1106-1111, 2022.
Article in Chinese | GIM | ID: covidwho-2314650

ABSTRACT

ObjectiveTo analyze the influenza surveillance data in Ezhou City, Hubei Province from 2016 to 2021, determine the epidemiological characteristics and etiological trend of influenza like illness (ILI), and to provide scientific evidence for influenza prevention and control. MethodsThe ILI surveillance data were reported by Ezhou influenza sentinel hospitals and etiological examination results were collected by network laboratory. Influenza surveillance data from 2016 to 2021 were analyzed. ResultsFrom 2016 to 2021, the percentage of ILI visits (ILI%) in Ezhou city was 2.81% and increased over years. Majority (55.55%) of ILI cases were 0-4 years. A total of 7 716 ILI samples were examined from 2016 to 2021, of which 1 467 tested positive with a positive rate of 19.01%. Influenza A H1N1 was mainly concentrated in January-April, A H3N2 mainly in August-December, B Victoria mainly in April-July and December-March, and B Yamagata mainly in December-February. Influenza network laboratory isolated influenza virus from the 1 467 positive samples by using MDCK cells and SPF chicken embryos. The overall isolation rate was 32.78%, which was 26.93% by MDCK cells and 5.86% by SPF chicken embryos. From 2016 to 2021, a total of 13 ILI outbreaks were reported in Ezhou City. Temporally, the outbreaks mainly occurred in winter and spring. Spatially, they were mainly in primary schools, middle schools and kindergartens. ConclusionThe winter and spring are the key time period of influenza prevention and control in Ezhou City, as they are susceptible to influenza outbreaks. Children aged 0-14 are the key population of prevention and control. Diverse subtypes of influenza virus alternate by years, which warrants continually strengthening monitoring. Additionally, certain countermeasures against COVID-19 may be recommended in the prevention and control of influenza.

2.
Disease Surveillance ; 38(2):135-138, 2023.
Article in Chinese | GIM | ID: covidwho-2294452

ABSTRACT

Objective: To assess the risk of public health emergencies occurring in China (except Hong Kong, Macao Special Administrative Regions and Taiwan Province, the same below) or possibly imported from outside China in February 2023. Methods: Based on various data and departmental notification information on domestic and foreign public health emergencies reports and surveillance of key infectious diseases, the expert consultation method was used and experts from provincial (autonomous regions and municipalities directly under the central government) centers for disease prevention and control were invited to participate in the assessment by video conference. Results: The number of public health emergencies to be reported in February 2023 is expected to increase compared to former month. In February 2023, affected by immune escape and reinfection of Omicron variants XBB, CH and other possible emerging subtypes, it is expected that the COVID-19 may become endemic in more areas of the world. In China, because of the increased flow of people after the Spring Festival and the opening of schools, the possibility of the spread of the virus will increase. The influenza viruses activity level may increase in February, and influenza A (H1N1) is more likely to be the main influenza virus. Conclusion: Special attention is given to COVID-19, and general attention is given to seasonal influenza.

3.
Gaceta Medica Estudiantil ; 3(1), 2022.
Article in Spanish | CAB Abstracts | ID: covidwho-2252819

ABSTRACT

Introduction: throughout history, several diseases have put mankind "in stress" and due to the accelerated and extensive spread have been labeled as pandemics. Background: to assess similarities and differences between COVID-19 and the Spanish influenza. Method: a literature review was carried out in December 2021. Using several Academic search engines, like (Pubmed, Google and Google Scholar). It was assessed several Articles published in Spanish;those that did not meet these conditions were excluded;89 bibliographic references were studied, of which 25 were cited in this article. Development: COVID-19 and Spanish flu are similar for arising respiratory symptoms at first, clinical characteristic of a common cold. The earliest documented case of Spanish flu was in the United States of America and it was caused by the H1N1 influenza A virus and it's not identified as a zoonosis, however, COVID-19 first cases were documented in China and it was caused by the virus of SARS-CoV-2, virus identified as a zoonosis that affect most commonly older adults, whereas the Spanish flu affected more young adults. It has been attributed some protective immunity to those who became ill with the Spanish flu, however, the coronavirus does not leave person with immunization levels after been infected. Conclusion: Spanish flu and coronavirus are the two great pandemics of history which have many similarities and differences from clinical, epidemiological and social point of view.

4.
Inserto BEN Bollettino Epidemiologico Nazionale ; 3(4):29-30, 2022.
Article in Italian | GIM | ID: covidwho-2278431

ABSTRACT

This article discussed the evolution of the InfluNet surveillance system in Italy, which was originally developed in 1999-2000 for monitoring flu-like syndromes and the circulation of influenza viruses. After the 2009-2010 subtype A/H1N1pdm09 influenza pandemic, InfluNet became an integrated surveillance system, including epidemiological and virological surveillance, as well as other sources of data to monitor the impact of influenza. The system proved to be a useful tool for assessing vaccine efficacy and preventing serious and severe forms of flu, especially in frail subjects. The SARS-CoV-2 pandemic introduced further innovations in InfluNet surveillance, and starting from the 2020-2021 season, InfluNet became a respiratory virus surveillance system. The article also described the trends of the 2021-2022 influenza season, with a low incidence of ILI and limited circulation of influenza viruses compared to seasons prior to 2020, as well as the impact of RSV. The article emphasized the importance of vaccination programs and the need for integrated surveillance systems to prevent the spread of respiratory diseases and deal with future pandemics.

5.
Revista Medica de Chile ; 150(3):316-323, 2022.
Article in Spanish | GIM | ID: covidwho-2218934

ABSTRACT

Background: In a decade, we faced two pandemic viruses, influenza A H1N1pdm09 and SARS CoV-2, whose most serious manifestation is pneumonia. Aim: To compare the clinical, epidemiological and management aspects of pneumonias caused by each pandemic virus in adults requiring hospitalization. Material and methods: Comparative, observational study carried out at a regional Chilean hospital, including 75 patients with influenza A H1N1pdm09 prospectively studied in 2009 and 142 patients with SARS CoV-2 studied in 2020.

6.
HPS Weekly Report ; 55:35, 2021.
Article in English | CAB Abstracts | ID: covidwho-2033645

ABSTRACT

This study presents the current epidemiological scenario for influenza in EU and EEA countries. Results showed that no human cases of avian influenza were reported in the EU and EEA for 2020. Sporadic human cases of avian influenza A(H5N1), A(H5N6), A(H5N8) and A(H9N2) infection were reported. In 2020, outbreaks and detections of highly pathogenic avian influenza viruses, mainly A(H5) of clade 2.3.4.4, continued to affect poultry, wild and captured birds worldwide. Influenza virus A(H1N1)v, A(H1N2)v and A(H3N2)v of swine origin caused sporadic human cases in Brazil, Canada, China, Germany, the Netherlands, and the USA. Slightly more human cases were identified, possibly due to greater awareness, combined with more targeted testing in those with respiratory symptoms during the ongoing COVID-19 pandemic. Therefore, for the EU and EEA, influenza activity remained at, or below, inter-seasonal levels throughout the 2020 to 2021 season, possibly due to the impact of the various public health and social measures implemented to reduce transmission of SARS-CoV-2.

7.
Shanghai Journal of Preventive Medicine ; 33(1):67-72, 2021.
Article in Chinese | GIM | ID: covidwho-1865682

ABSTRACT

Objective: To compare the response measures and outcomes of SARS-CoV(2003), H1N1 influenza(2009), H7N9 influenza(2013)and COVID-19(2020)in Shanghai and provide scientific evidence for the emergency response of public health emergencies.

8.
Chinese Journal of Integrated Traditional and Western Medicine ; 42(2):232-235, 2022.
Article in Chinese, English | CAB Abstracts | ID: covidwho-1824044

ABSTRACT

Many viral diseases are highly contagious, and correlated with poor prognosis and great harm. Chinese medicine(CM) has played an important role in the prevention and treatment of viral diseases, including epidemic encephalitis B, epidemic hemorrhagic fever, viral hepatitis A, SARS, H1 N1 influenza and COVID-19, and performs better in improving symptoms, shorting the course of disease, delaying disease progression, increasing clinical cure rate and reducing mortality compared with symptomatic and supportive treatment alone. We retrospectively analyze the role of CM in the prevention and treatment of viral diseases, thus to provide reference for clinical practice.

9.
Disease Surveillance ; 36(12):1302-1307, 2021.
Article in Chinese | GIM | ID: covidwho-1756470

ABSTRACT

Objective: To understand the epidemiological and etiological characteristics of influenza-like illness (ILI) in Zhenjiang, Jiangsu province, during 2013-2020, and provide scientific basis for the prevention and control of influenza.

10.
Turkish Journal of Public Health ; 18(1):99-102, 2020.
Article in Turkish | CAB Abstracts | ID: covidwho-1727119

ABSTRACT

Since the day I started to write this article, there have been so many new developments in the world and in our country, even in the last 4 days, evaluating new information, reading what is written, making sense of interpretations, causes ones thoughts to jump from one point to another. I realized that it is not possible to prepare a systematic article that covers the subject completely. I started by making a list of messages and observations in my mind and sharing them with you. The pandemic experience was not the first in our working life, but the closest was the H1N1 pandemic in the 2009-2010 season. In our country, a total of 13,591 cases and 656 deaths due to pandemic influenza virus were confirmed. Hospitalization rate was 1.4%;the rate of hospitalization to intensive care unit was 13.6% and the mortality rate in intensive care patients was 19.6%.

11.
Sustain Cities Soc ; 70: 102887, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1157725

ABSTRACT

The fast spread of SARS-CoV-2 presented a worldwide challenge to public health, economy, and educational system, affecting wellbeing of human society. With high transmission rates, there are increasing evidences of COVID-19 spread via bioaerosols from an infected person. The current review was conducted to examine airborne pollen impact on COVID-19 transmission and to identify the major gaps for post-pandemic research. The study used all key terms to identify revenant literature and observation were collated for the current research. Based on existing literature, there is a potential association between pollen bioaerosols and COVID-19. There are few studies focusing the impact of airborne pollen on SARS-CoV-2, which could be useful to advance future research. Allergic rhinitis and asthma patients were found to have pre-modified immune activation, which could help to provide protection against COVID-19. However, does airborne pollen acts as a potent carrier for SARS-CoV-2 transport, dispersal and its proliferation still require multidisciplinary research. Further, a clear conclusion cannot be drawn due to limited evidence and hence more research is needed to show how pollen bioaerosols could affect virus survivals. The small but growing literature review focuses on searching for every possible answer to provide additional security layers to overcome near future corona-like infectious diseases.

12.
J Biosaf Biosecur ; 2(1): 5-9, 2020 Mar.
Article in English | MEDLINE | ID: covidwho-381755

ABSTRACT

The outbreak of the coronavirus disease 2019 (COVID-19) in December 2019 highlighted several concerns regarding hospital biosafety capacitation in the People's Republic of China, although the epidemic is now under control. This study examined the primary problems related to hospital biosecurity, including the absence of a hospital emergency system, inadequate management and control of nosocomial infection, limited hospital laboratory capacity, and poor hospital admission capacity. Accordingly, this study puts forward the following countermeasures and suggestions for hospitals to deal with future biosecurity events, such as a major epidemic: first, biosecurity management systems and emergency response mechanisms in hospitals need to be set up; second, the investment and guarantee mechanisms for hospital biosecurity construction should be improved; third, the capacity building of biosecurity incident management requires special attention in general hospitals; and finally, comprehensive plans need to be developed for the integrated construction of medical treatment and prevention facilities through disease-control systems.

SELECTION OF CITATIONS
SEARCH DETAIL